Background The SARS-CoV-2 outbreak poses a challenge to health care systems due to its
high complication rates in patients with cardiometabolic diseases. Here, we identify risk …

Familial combined hyperlipidemia (FCHL) is the most prevalent primary dyslipidemia; however,
it frequently remains undiagnosed and its precise definition is a subject of controversy. …

Objective We developed a novel non-insulin-based fasting score to evaluate insulin sensitivity
validated against the euglycemic–hyperinsulinemic clamp (EHC). We also evaluated its …

Background COVID-19 has had a disproportionate impact on older adults. Mexico’s population
is younger, yet COVID-19’s impact on older adults is comparable to countries with older …

The Islamic Republic of Iran reported its first COVID-19 cases by 19 th February 2020, since
then it has become one of the most affected countries, with more than 73,000 cases and …

Introduction Diabetes and hyperglycemia are risk factors for critical COVID-19 outcomes;
however, the impact of pre-diabetes and previously unidentified cases of diabetes remains …

OBJECTIVE To estimate diabetes-related mortality in Mexico in 2020 compared with 2017–2019
after the onset of the coronavirus disease 2019 (COVID-19) pandemic. RESEARCH …

Background In 2020, Mexico experienced one of the highest rates of excess mortality globally.
However, the extent of non-COVID deaths on excess mortality, its regional distribution …

Background & aims Intra-abdominal and visceral fat (VAT) are risk factors for the development
of cardio-metabolic comorbidities; however its clinical assessment is limited by technology …

Background and purpose Information on Guillain–Barré syndrome (GBS) as an adverse event
following immunization (AEFI) against SARS‐CoV‐2 remains scarce. We aimed to report …